Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Zhou, Yang ^a,b   Murthy, Jayasimha N ^a   Zeng, Dewan ^c   Belardinelli, Luiz ^c   Blackburn, Michael R ^a,b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c Gilead Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; INTERLEUKIN 6; INTERLEUKIN 8; OSTEOPONTIN; 3 ETHYL 1 PROPYL 8 (1 (3 TRIFLUOROMETHYLBENZYL) 1H PYRAZOL 4 YL) 3,7 DIHYDROPURINE 2,6 DIONE; 3-ETHYL-1-PROPYL-8-(1-(3-TRIFLUOROMETHYLBENZYL)-1H-PYRAZOL-4-YL)-3,7-DIHYDROPURINE-2,6-DIONE; ADENOSINE RECEPTOR; PURINE DERIVATIVE; PYRAZOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; INFLAMMATION; LUNG BIOPSY; MACROPHAGE; MALE; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; CELL CULTURE; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSCRIPTION; GENETICS; LUNG; LUNG ALVEOLUS MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION;

5'-NUCLEOTIDASE; ADENOSINE; ADULT; AGED; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; MACROPHAGES, ALVEOLAR; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PURINES; PYRAZOLES; RECEPTORS, PURINERGIC P1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 77949518257     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009224     Document Type: Article

References (51)

1. Ward PA, HunninghakeGW(1998) Lung inflammation and fibrosis. Am J Respir Crit Care Med 157: S123-129.
2. Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ (2004) Mechanisms of pulmonary fibrosis. Annu Rev Med 55: 395-417.
3. Blackburn MR (2003) Too much of a good thing: adenosine overload in adenosine-deaminase-deficient mice. Trends Pharmacol Sci 24: 66-70.
4. Driver AG, Kukoly CA, Ali S, Mustafa SJ (1993) Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97.
5. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, et al. (2002) Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20: 1393-1398.
6. Mann JS, Holgate ST, Renwick AG, Cushley MJ (1986) Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 61: 1667-1676.
7. Zhou Y, Schneider DJ, Blackburn MR (2009) Adenosine signaling and the regulation of chronic lung disease. Pharmacol Ther 123: 105-116.
8. Fredholm BB, AP IJ, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
9. Brown RA, Clarke GW, Ledbetter CL, Hurle MJ, Denyer JC, et al. (2008) Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31: 311-319.
10. Walker BA, Jacobson MA, Knight DA, Salvatore CA, Weir T, et al. (1997) Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16: 531-537.
11. Varani K, Caramori G, Vincenzi F, Adcock I, Casolari P, et al. (2006) Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173: 398-406.
12. Selman M, Carrillo G, Estrada A, Mejia M, Becerril C, et al. (2007) Accelerated variant of idiopathic pulmonary fibrosis: clinical behavior and gene expression pattern. PLoS ONE 2: e482.
13. Elias JA, Zhu Z, Chupp G, Homer RJ (1999) Airway remodeling in asthma. J Clin Invest 104: 1001-1006.
14. Fozard JR, Hannon JP (1999) Adenosine receptor ligands: potential as therapeutic agents in asthma and COPD. Pulm Pharmacol Ther 12: 111-114.
15. Cushley MJ, Tattersfield AE, Holgate ST (1983) Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15: 161-165.
16. Oosterhoff Y, de Jong JW, Jansen MA, Koeter GH, Postma DS (1993) Airway responsiveness to adenosine 59-monophosphate in chronic obstructive pulmonary disease is determined by smoking. Am Rev Respir Dis 147: 553-558.
17. Marquardt DL, Parker CW, Sullivan TJ (1978) Potentiation of mast cell mediator release by adenosine. J Immunol 120: 871-878.
18. Hasko G, Szabo C, Nemeth ZH, Kvetan V, Pastores SM, et al. (1996) Adenosine receptor agonists differentially regulate IL-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages and in endotoxemic mice. J Immunol 157: 4634-4640.
19. Johnson HG, McNee ML (1985) Adenosine-induced secretion in the canine trachea: modification by methylxanthines and adenosine derivatives. Br J Pharmacol 86: 63-67.
20. Zhong H, Belardinelli L, Maa T, Zeng D (2005) Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts. Am J Respir Cell Mol Biol 32: 2-8.
21. Ali S, Mustafa SJ, Metzger WJ (1994) Adenosine-induced bronchoconstriction and contraction of airway smooth muscle from allergic rabbits with late-phase airway obstruction: evidence for an inducible adenosine A1 receptor. J Pharmacol Exp Ther 268: 1328-1334.
22. Roman J, Rivera HN, Roser-Page S, Sitaraman SV, Ritzenthaler JD (2006) Adenosine induces fibronectin expression in lung epithelial cells: implications for airway remodeling. Am J Physiol Lung Cell Mol Physiol 290: L317-325.
23. Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, et al. (2003) Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 112: 332-344.
24. Ma B, Blackburn MR, Lee CG, Homer RJ, Liu W, et al. (2006) Adenosine metabolism and murine strain-specific IL-4-induced inflammation, emphysema, and fibrosis. J Clin Invest 116: 1274-1283.
25. Volmer JB, Thompson LF, Blackburn MR (2006) Ecto-5′-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury. J Immunol 176: 4449-4458.
26. Zaynagetdinov R, Ryzhov S, Goldstein AE, Yin H, Novitskiy SV, et al. (2009) Attenuation of Chronic Pulmonary Inflammation in A2B Adenosine Receptor Knockout Mice. Am J Respir Cell Mol Biol.
27. Blackburn MR, Volmer JB, Thrasher JL, Zhong H, Crosby JR, et al. (2000) Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192: 159-170.
28. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, et al. (2005) A protective role for the A(1) adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115: 35-43.
29. Chunn JL, Molina JG, Mi T, Xia Y, Kellems RE, et al. (2005) Adenosine-dependent pulmonary fibrosis in adenosine deaminase-deficient mice. J Immunol 175: 1937-1946.
30. Sun CX, Zhong H, Mohsenin A, Morschl E, Chunn JL, et al. (2006) Role of A2B adenosine receptor signaling in adenosine-dependent pulmonary inflammation and injury. J Clin Invest 116: 2173-2182.
31. Young HW, Molina JG, Dimina D, Zhong H, Jacobson M, et al. (2004) A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173: 1380-1389.
32. Lupher ML Jr, Gallatin WM (2006) Regulation of fibrosis by the immune system. Adv Immunol 89: 245-288.
33. Strieter RM (2008) What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc Am Thorac Soc 5: 305-310.
34. Feoktistov I, Biaggioni I (1995) Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma. J Clin Invest 96: 1979-1986.
35. Ryzhov S, Goldstein AE, Matafonov A, Zeng D, Biaggioni I, et al. (2004) Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma. J Immunol 172: 7726-7733.
36. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Blackburn MR, et al. (2008) Effect of A2B adenosine receptor gene ablation on adenosine-dependent regulation of proinflammatory cytokines. J Pharmacol Exp Ther 324: 694-700.
37. Ryzhov S, Zaynagetdinov R, Goldstein AE, Novitskiy SV, Dikov MM, et al. (2008) Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells. J Immunol 180: 7212-7220.
38. Yang D, Zhang Y, Nguyen HG, Koupenova M, Chauhan AK, et al. (2006) The A2B adenosine receptor protects against inflammation and excessive vascular adhesion. J Clin Invest 116: 1913-1923.
39. Zhong H, Belardinelli L, Maa T, Feoktistov I, Biaggioni I, et al. (2004) A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. Am J Respir Cell Mol Biol 30: 118-125.
40. Mann JS, Renwick AG, Holgate ST (1986) Release of adenosine and its metabolites from activated human leucocytes. Clin Sci (Lond) 70: 461-468.
41. Vizi E, Huszar E, Csoma Z, Boszormenyi-Nagy G, Barat E, et al. (2002) Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma. J Allergy Clin Immunol 109: 446-448.
42. Li Y, Wang W, Parker W, Clancy JP (2006) Adenosine regulation of cystic fibrosis transmembrane conductance regulator through prostenoids in airway epithelia. Am J Respir Cell Mol Biol 34: 600-608.
43. Picher M, Burch LH, Boucher RC (2004) Metabolism of P2 receptor agonists in human airways: implications for mucociliary clearance and cystic fibrosis. J Biol Chem 279: 20234-20241.
44. Blackburn MR, Kellems RE (2005) Adenosine deaminase deficiency: metabolic basis of immune deficiency and pulmonary inflammation. Adv Immunol 86: 1-41.
45. Berkvens TM, Schoute F, van Ormondt H, Meera Khan P, van der Eb AJ (1988) Adenosine deaminase gene expression is regulated posttranscriptionally in the nucleus. Nucleic Acids Res 16: 3255-3268.
46. Chunn JL, Young HW, Banerjee SK, Colasurdo GN, Blackburn MR (2001) Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice. J Immunol 167: 4676-4685.
47. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-770.
48. Fredholm BB (2007) Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ 14: 1315-1323.
49. Feoktistov I, Biaggioni I (1997) Adenosine A2B receptors. Pharmacol Rev 49: 381-402.
50. Eckle T, Faigle M, Grenz A, Laucher S, Thompson LF, et al. (2008) A2B adenosine receptor dampens hypoxia-induced vascular leak. Blood 111: 2024-2035.
51. Mohsenin A, Burdick MD, Molina JG, Keane MP, Blackburn MR (2007) Enhanced CXCL1 production and angiogenesis in adenosine-mediated lung disease. Faseb J 21: 1026-1036.